抗菌治療法の世界市場予測・分析:用途別・地域別

◆英語タイトル:Antimicrobial Therapeutics Market by Application and Geography - Global Forecast and Analysis 2019-2023
◆商品コード:IRTNTR31420
◆発行会社(リサーチ会社):Technavio
◆発行日:2019年6月19日
◆ページ数:135
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:アジア、ヨーロッパ、北米、その他
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Technavio社の本調査レポートでは、抗菌治療法の世界市場について調べ、抗菌治療法の市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、抗菌治療法の市場規模をセグメンテーション別(用途別(抗ウイルス薬、抗菌、抗真菌、駆虫剤)、)と地域別(アジア、ヨーロッパ、北米、その他)に分けて算出しました。Technavio社は抗菌治療法の世界市場規模が2019-2023期間中に年平均4%成長すると予測しています。
・サマリー
・レポートの範囲
・抗菌治療法の市場状況
・抗菌治療法の市場規模
・抗菌治療法の市場予測
・抗菌治療法の世界環境:ファイブフォース分析
・市場セグメンテーション:用途別(抗ウイルス薬、抗菌、抗真菌、駆虫剤)
・抗菌治療法の顧客状況
・主要地域別市場規模:アジア、ヨーロッパ、北米、その他
・意思決定フレームワーク
・市場動向・成長要因・課題
・関連企業状況・企業分析
 ...
【レポートの概要】

Global Antimicrobial Therapeutics Market: About this market

Antimicrobial drugs include antibiotics, antifungals, antiprotozoal, and antivirals, which help kill microorganisms or inhibit their growth. Technavio’s antimicrobial therapeutics market analysis considers sales from applications including antiviral, antibacterial, antifungal, and antiparasitic. Our analysis also considers the sales of antimicrobial therapeutics in Asia, Europe, North America, and ROW. In 2018, the antiviral segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the rising incidence of viral infections, including HIV, hepatitis, and influenza, will play a significant role in the antiviral segment to maintain its market position. Also, our global antimicrobial therapeutics market report looks at factors such as recent drug approvals and robust pipeline, initiatives from government agencies, and rising awareness about microbial diseases. However, the increasing availability of generic drugs, challenges associated with development, storage, and handling of vaccines, and rising antimicrobial resistance may hamper the growth of the antimicrobial therapeutics industry over the forecast period.

Global Antimicrobial Therapeutics Market: Overview

Recent drug approvals and robust pipeline

Researchers are investing in R&D on new drugs and vaccines due to the growing prevalence of microbial diseases. This has created a strong drug pipeline involving innovative disease-modifying agents. Researchers are also focusing on the development of several advanced novel therapeutic solutions. The approval of these vaccines and therapeutic solutions will lead to the expansion of the global antimicrobial therapeutics market at a CAGR of almost 4% during the forecast period.

Increase in disease diagnostic modalities

There is an increase in the demand for high-quality diagnostics that will enable early diagnosis of the infection. This is encouraging various companies to develop sophisticated diagnostic modalities, biomarkers, and PoC diagnostic tests. The development of such innovative diagnostics is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global antimicrobial therapeutics market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of a few major players, the global antimicrobial therapeutics market is concentrated. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antimicrobial therapeutics manufacturers, that include Gilead Sciences, Inc., GlaxoSmithKline plc, Merck & Co Inc., Pfizer Inc., and Sanofi.

Also, the antimicrobial therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: MARKET SEGMENTATION BY APPLICATION

Market segmentation by application

Comparison by application

Antiviral – Market size and forecast 2018-2023

Antibacterial – Market size and forecast 2018-2023

Antifungal – Market size and forecast 2018-2023

Antiparasitic – Market size and forecast 2018-2023

Market opportunity by application

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

Asia – Market size and forecast 2018-2023

ROW – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 11: MARKET TRENDS

Increase in R&D of therapeutic vaccines

Increased disease diagnostic modalities

PART 12: VENDOR LANDSCAPE

Overview

Landscape disruption

PART 13: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

Gilead Sciences, Inc.

GlaxoSmithKline plc

Merck & Co Inc.

Pfizer Inc.

Sanofi

PART 14: APPENDIX

Research methodology

List of abbreviations

Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

Exhibit 01: Global pharmaceuticals market

Exhibit 02: Segments of global pharmaceuticals market

Exhibit 03: Market characteristics

Exhibit 04: Market segments

Exhibit 05: Market definition – Inclusions and exclusions checklist

Exhibit 06: Market size 2018

Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 09: Five forces analysis 2018

Exhibit 10: Five forces analysis 2023

Exhibit 11: Bargaining power of buyers

Exhibit 12: Bargaining power of suppliers

Exhibit 13: Threat of new entrants

Exhibit 14: Threat of substitutes

Exhibit 15: Threat of rivalry

Exhibit 16: Market condition – Five forces 2018

Exhibit 17: Application – Market share 2018-2023 (%)

Exhibit 18: Comparison by application

Exhibit 19: Antiviral – Market size and forecast 2018-2023 ($ millions)

Exhibit 20: Antiviral – Year-over-year growth 2019-2023 (%)

Exhibit 21: Antibacterial – Market size and forecast 2018-2023 ($ millions)

Exhibit 22: Antibacterial – Year-over-year growth 2019-2023 (%)

Exhibit 23: Antifungal – Market size and forecast 2018-2023 ($ millions)

Exhibit 24: Antifungal – Year-over-year growth 2019-2023 (%)

Exhibit 25: Antiparasitic – Market size and forecast 2018-2023 ($ millions)

Exhibit 26: Antiparasitic – Year-over-year growth 2019-2023 (%)

Exhibit 27: Market opportunity by application

Exhibit 28: Customer landscape

Exhibit 29: Market share by geography 2018-2023 (%)

Exhibit 30: Geographic comparison

Exhibit 31: North America – Market size and forecast 2018-2023 ($ millions)

Exhibit 32: North America – Year-over-year growth 2019-2023 (%)

Exhibit 33: Europe – Market size and forecast 2018-2023 ($ millions)

Exhibit 34: Europe – Year-over-year growth 2019-2023 (%)

Exhibit 35: Asia – Market size and forecast 2018-2023 ($ millions)

Exhibit 36: Asia – Year-over-year growth 2019-2023 (%)

Exhibit 37: ROW – Market size and forecast 2018-2023 ($ millions)

Exhibit 38: ROW – Year-over-year growth 2019-2023 (%)

Exhibit 39: Key leading countries

Exhibit 40: Market opportunity

Exhibit 41: Some of the late-stage molecules

Exhibit 42: Impact of drivers and challenges

Exhibit 43: Therapeutic vaccines

Exhibit 44: Some of the recent POC diagnostics approvals in the US

Exhibit 45: Some of the recently approved combination therapy drugs

Exhibit 46: Vendor landscape

Exhibit 47: Landscape disruption

Exhibit 48: Vendors covered

Exhibit 49: Vendor classification

Exhibit 50: Market positioning of vendors

Exhibit 51: Gilead Sciences, Inc. – Vendor overview

Exhibit 52: Gilead Sciences, Inc. – Business segments

Exhibit 53: Gilead Sciences, Inc. – Organizational developments

Exhibit 54: Gilead Sciences, Inc. – Geographic focus

Exhibit 55: Gilead Sciences, Inc. – Segment focus

Exhibit 56: Gilead Sciences, Inc. – Key offerings

Exhibit 57: GlaxoSmithKline plc – Vendor overview

Exhibit 58: GlaxoSmithKline plc – Business segments

Exhibit 59: GlaxoSmithKline plc – Organizational developments

Exhibit 60: GlaxoSmithKline plc – Geographic focus

Exhibit 61: GlaxoSmithKline plc – Segment focus

Exhibit 62: GlaxoSmithKline plc – Key offerings

Exhibit 63: GlaxoSmithKline plc – Key offerings

Exhibit 64: Merck & Co Inc. – Vendor overview

Exhibit 65: Merck & Co Inc. – Business segments

Exhibit 66: Merck & Co Inc. – Organizational developments

Exhibit 67: Merck & Co Inc. – Geographic focus

Exhibit 68: Merck & Co Inc. – Segment focus

Exhibit 69: Merck & Co Inc. – Key offerings

Exhibit 70: Pfizer Inc. – Vendor overview

Exhibit 71: Pfizer Inc. – Business segments

Exhibit 72: Pfizer Inc. – Organizational developments

Exhibit 73: Pfizer Inc. – Geographic focus

Exhibit 74: Pfizer Inc. – Segment focus

Exhibit 75: Pfizer Inc. – Key offerings

Exhibit 76: Sanofi – Vendor overview

Exhibit 77: Sanofi – Business segments

Exhibit 78: Sanofi – Organizational developments

Exhibit 79: Sanofi – Geographic focus

Exhibit 80: Sanofi – Segment focus

Exhibit 81: Sanofi – Key offerings

Exhibit 82: Validation techniques employed for market sizing

Exhibit 83: Definition of market positioning of vendors



【掲載企業】

Gilead Sciences, Inc.
GlaxoSmithKline plc
Merck & Co Inc.
Pfizer Inc.
Sanofi

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[抗菌治療法の世界市場予測・分析:用途別・地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆